DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

Translate to Spanish or other 102 languages!

Dr. R. Alejandro Cruz, DHR Health Neurologist. Photo Courtesy DHR Health
- Advertisement -

Edinburg, Texas: DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

Under the expert guidance of neurologist Dr. R. Alejandro Cruz and the dedicated team at the DHR Health Neuroscience Institute, comprehensive protocols have been meticulously developed for administering Leqembi. These protocols encompass every aspect of patient care, from initial assessments to laboratory testing, radiology procedures, and establishing a state-of-the-art infusion center.

“I am very proud of the hard work of our team at DHR Health. Being the first facility to provide this groundbreaking therapy for Alzheimer’s disease marks a new era of hope for our community,” said Dr. R. Alejandro Cruz, DHR Health Neurologist.

- Advertisement -

As the largest physician-owned hospital in the United States and a leading healthcare provider in the Rio Grande Valley, DHR Health is immensely proud to be at the forefront of Alzheimer’s disease treatment in South Texas. “This achievement represents our ongoing commitment to bringing innovative and advanced treatment options to our community. We are proud to provide world-class care close to home,” said Marissa Castañeda, Senior Executive Vice President at DHR Health.

Dr. Cruz explains that Alzheimer’s disease is a progressive brain disorder characterized by changes in the brain that lead to the accumulation of certain proteins. These changes cause the brain to shrink and brain cells to die, resulting in dementia, which manifests as a gradual decline in memory, thinking, behavior, and social skills. The introduction of Leqembi offers hope for those affected by this debilitating condition, with the potential to improve quality of life and slow disease progression.

DHR Health continues delivering exceptional care, announcing a new chapter in Alzheimer’s treatment for the Rio Grande Valley. If you or a loved one are affected by Alzheimer’s, we encourage you to take the next step. To learn more about this groundbreaking treatment or to make an appointment, please contact the DHR Health Neuroscience Institute at (956) 362-8500.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Salmonella Outbreak Linked to Shell Eggs

CDC, FDA, and public health officials in several states are investigating a multistate outbreak of Salmonella infections linked to shell eggs. If you have recalled shell eggs in your home or business, throw them out or return them

STHS Edinburg Celebrates Dr. Bob Saggi’s 2,000th Robotic Surgery Milestone

Robotic-assisted surgery has transformed the way many complex procedures are performed, offering surgeons enhanced precision, greater flexibility and improved visualization while helping patients benefit from smaller incisions, less pain and faster recoveries.

Elevating Concussion Safety for Youth Sports

If your child is going to be playing football or another contact sport this fall, it’s important to know the signs and symptoms of a concussion – especially since they may not always be easy to detect.

STHS Behavioral Offers Back-to-School Mental Health Tips

If you’re worried about your child’s mental health, STHS Behavioral can help. For a confidential assessment, call the facility’s hotline at 956-388-1300 or visit southtexashealthsystembehavioral.com. Licensed mental health professionals are available 24 hours a day, 7 days a week to assist you or a loved one.
- Advertisement -